{"transactions":[{"id":1590884,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-03-06T18:45:39.000Z","date":"2024-03-05","kind":"sale","planned":true,"acquired":false,"shares":3300,"price":7.0003,"value":23100.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $7.00 to $7.01. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 50,000 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":245346,"source":{"system":"sec-edgar","filing":"0000950170-24-027442","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553333/000095017024027442/ownership.xml","form_type":"4"}},{"id":1614677,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2024-02-27T19:31:13.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":75000,"derivative":{"exercise_price":5.22,"exercise_date":"2024-03-23","expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000950170-24-021550","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553333/000095017024021550/ownership.xml","form_type":"4"}},{"id":1614676,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-27T19:31:13.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on August 15, 2024, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 50,000 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":248646,"source":{"system":"sec-edgar","filing":"0000950170-24-021550","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553333/000095017024021550/ownership.xml","form_type":"4"}},{"id":1628177,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-21T18:05:34.000Z","date":"2024-02-20","kind":"sale","planned":true,"acquired":false,"shares":200,"price":6.165,"value":1233.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $6.16 to $6.17. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":236146,"source":{"system":"sec-edgar","filing":"0000950170-24-018222","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553333/000095017024018222/ownership.xml","form_type":"4"}},{"id":1628176,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-21T18:05:34.000Z","date":"2024-02-20","kind":"sale","planned":true,"acquired":false,"shares":6369,"price":5.309,"value":33813.021,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $5.13 to $6.07. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 37,500 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":236346,"source":{"system":"sec-edgar","filing":"0000950170-24-018222","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553333/000095017024018222/ownership.xml","form_type":"4"}},{"id":1637612,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-16T20:37:46.000Z","date":"2024-02-16","kind":"sale","planned":false,"acquired":false,"shares":4681,"price":5.86,"value":27430.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $5.61 to $6.15. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 37,500 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":242715,"source":{"system":"sec-edgar","filing":"0000950170-24-016673","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553333/000095017024016673/ownership.xml","form_type":"4"}},{"id":1793921,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-08-29T18:59:27.000Z","date":"2023-08-29","kind":"sale","planned":true,"acquired":false,"shares":7243,"price":4.26,"value":30855.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $4.11 to $4.36. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 48,750 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":247396,"source":{"system":"sec-edgar","filing":"0001209191-23-047673","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553333/000120919123047673/doc4.xml","form_type":"4"}},{"id":1801618,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-08-18T18:34:51.000Z","date":"2023-08-16","kind":"sale","planned":false,"acquired":false,"shares":4007,"price":3.81,"value":15266.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $3.76 to $3.87. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 48,750 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":254639,"source":{"system":"sec-edgar","filing":"0001209191-23-046642","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553333/000120919123046642/doc4.xml","form_type":"4"}},{"id":2006611,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2023-02-17T18:48:57.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":175000,"derivative":{"exercise_price":3.06,"exercise_date":"2023-03-15","expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-23-010887","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553333/000120919123010887/doc4.xml","form_type":"4"}},{"id":2006610,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-02-17T18:48:57.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F4","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the total number of shares subject to the restricted stock unit award on each of August 15, 2023, February 15, 2024, August 15, 2024 and February 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 60,000 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":258646,"source":{"system":"sec-edgar","filing":"0001209191-23-010887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553333/000120919123010887/doc4.xml","form_type":"4"}},{"id":2006609,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-02-17T18:48:57.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on the six month anniversary of the Transaction Date, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 30,000 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":228646,"source":{"system":"sec-edgar","filing":"0001209191-23-010887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553333/000120919123010887/doc4.xml","form_type":"4"}},{"id":2288582,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-04-28T19:57:56.000Z","date":"2022-04-26","kind":"sale","acquired":false,"shares":1353,"price":10.13,"value":13705.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 12, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $10.02 to $10.33. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":198646,"source":{"system":"sec-edgar","filing":"0001209191-22-026097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553333/000120919122026097/doc4.xml","form_type":"4"}},{"id":2387560,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2022-02-17T17:36:26.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":168000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one (1) month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":168000,"derivative":{"exercise_price":15.19,"exercise_date":"2022-03-15","expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":168000},"source":{"system":"sec-edgar","filing":"0001209191-22-010916","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553333/000120919122010916/doc4.xml","form_type":"4"}},{"id":4345507,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Cancer Biology & Co-CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-04-25T18:13:24.000Z","date":"2017-04-23","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of the date of grant, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":3.73,"expiration_date":"2027-04-22","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001140361-17-016768","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117016768/doc1.xml","form_type":"4"}},{"id":4345506,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Cancer Biology & Co-CSO"}}],"security":"Common Stock","published_at":"2017-04-25T18:13:24.000Z","date":"2017-04-23","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The reporting person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 32,500 RSUs."}],"balance_after":77225,"source":{"system":"sec-edgar","filing":"0001140361-17-016768","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117016768/doc1.xml","form_type":"4"}},{"id":4357950,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Cancer Biology & Co-CSO"}}],"security":"Common Stock","published_at":"2017-04-05T19:40:14.000Z","date":"2017-04-04","kind":"sale","acquired":false,"shares":5711,"price":9.0582,"value":51731.3802,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a sell-to-cover election made by the Reporting Person at the time of the initial grant of the restricted stock unit award, the shares were sold upon the vesting of restricted stock units solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 12,500 restricted stock units (\"RSUs\").  The reporting person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,000 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2017."}],"balance_after":57225,"source":{"system":"sec-edgar","filing":"0001140361-17-015047","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117015047/doc1.xml","form_type":"4"}},{"id":4357949,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Cancer Biology & Co-CSO"}}],"security":"Common Stock","published_at":"2017-04-05T19:40:14.000Z","date":"2017-04-04","kind":"sale","acquired":false,"shares":43,"price":8.8671,"value":381.2853,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a sell-to-cover election made by the Reporting Person at the time of the initial grant of the restricted stock unit award, the shares were sold upon the vesting of restricted stock units solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 12,500 restricted stock units (\"RSUs\").  The reporting person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,000 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2017."}],"balance_after":62936,"source":{"system":"sec-edgar","filing":"0001140361-17-015047","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117015047/doc1.xml","form_type":"4"}},{"id":4498500,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Cancer Biology & Co-CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-05T19:07:31.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of the date of grant, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":55000,"derivative":{"exercise_price":7.66,"expiration_date":"2027-01-02","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001140361-17-000848","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117000848/doc1.xml","form_type":"4"}},{"id":4498499,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Cancer Biology & Co-CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-05T19:07:31.000Z","date":"2017-01-03","kind":"exercise","acquired":false,"shares":12763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 21, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable, subject to an annual limitation of 175,438 shares that can be issued to a single grantee upon the exercise of awards under the Issuer's 2004 Stock Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":1.43,"expiration_date":"2017-01-11","underlying":"Common Stock","underlying_shares":12763},"source":{"system":"sec-edgar","filing":"0001140361-17-000848","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117000848/doc1.xml","form_type":"4"}},{"id":4498498,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Cancer Biology & Co-CSO"}}],"security":"Common Stock","published_at":"2017-01-05T19:07:31.000Z","date":"2017-01-03","kind":"sale","acquired":false,"shares":12763,"price":7.6352,"value":97448.0576,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 21, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $7.55 to $7.845, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 27,500 restricted stock units. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) restricted stock unit."}],"balance_after":60979,"source":{"system":"sec-edgar","filing":"0001140361-17-000848","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117000848/doc1.xml","form_type":"4"}},{"id":4498497,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Cancer Biology & Co-CSO"}}],"security":"Common Stock","published_at":"2017-01-05T19:07:31.000Z","date":"2017-01-03","kind":"exercise","acquired":true,"shares":12763,"price":1.43,"value":18251.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 21, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 27,500 restricted stock units. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) restricted stock unit."}],"balance_after":73742,"source":{"system":"sec-edgar","filing":"0001140361-17-000848","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117000848/doc1.xml","form_type":"4"}},{"id":4548611,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Cancer Biology & Co-CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-18T18:21:03.000Z","date":"2016-11-16","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 21, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable, subject to a limitation of 175,438 shares that can be issued to a single grantee in a 12-month period upon the exercise of awards under the Issuer's 2004 Stock Incentive Plan."}],"balance_after":12763,"derivative":{"exercise_price":1.43,"expiration_date":"2017-01-10","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001140361-16-087300","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036116087300/doc1.xml","form_type":"4"}},{"id":4548610,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Cancer Biology & Co-CSO"}}],"security":"Common Stock","published_at":"2016-11-18T18:21:03.000Z","date":"2016-11-16","kind":"sale","acquired":false,"shares":12500,"price":9.8887,"value":123608.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 21, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $9.65 to $10.05, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 12,500 restricted stock units. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) restricted stock unit."}],"balance_after":60979,"source":{"system":"sec-edgar","filing":"0001140361-16-087300","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036116087300/doc1.xml","form_type":"4"}},{"id":4548609,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Cancer Biology & Co-CSO"}}],"security":"Common Stock","published_at":"2016-11-18T18:21:03.000Z","date":"2016-11-16","kind":"exercise","acquired":true,"shares":12500,"price":1.43,"value":17875.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 21, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 12,500 restricted stock units. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) restricted stock unit."}],"balance_after":73479,"source":{"system":"sec-edgar","filing":"0001140361-16-087300","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036116087300/doc1.xml","form_type":"4"}},{"id":4581480,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":93413,"kind":"person","name":"Hoey Timothy","position":1,"cik":"0001553333","reported_name":"Hoey Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Co-CSO"}}],"security":"Common Stock","published_at":"2016-10-11T21:43:52.000Z","date":"2016-10-09","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The reporting person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 27,500 restricted stock units and 1,298 shares acquired under the Issuer's Employee Stock Purchase Plan on February 29, 2016."}],"balance_after":60979,"source":{"system":"sec-edgar","filing":"0001140361-16-082542","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036116082542/doc1.xml","form_type":"4"}}]}